The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-N-[4-[3-Cyano-1-(2-methyl-1-oxo-isoindolin-5-yl)indol-5-yl]oxyphenyl]pyrrolidine-2-carboxamide ID: ALA3422674
PubChem CID: 118735788
Max Phase: Preclinical
Molecular Formula: C29H25N5O3
Molecular Weight: 491.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1Cc2cc(-n3cc(C#N)c4cc(Oc5ccc(NC(=O)[C@@H]6CCCN6)cc5)ccc43)ccc2C1=O
Standard InChI: InChI=1S/C29H25N5O3/c1-33-16-18-13-21(6-10-24(18)29(33)36)34-17-19(15-30)25-14-23(9-11-27(25)34)37-22-7-4-20(5-8-22)32-28(35)26-3-2-12-31-26/h4-11,13-14,17,26,31H,2-3,12,16H2,1H3,(H,32,35)/t26-/m0/s1
Standard InChI Key: ZHZRYPWKMPTDMQ-SANMLTNESA-N
Molfile:
RDKit 2D
37 42 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1783 2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5503 3.7690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6187 1.4919 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6267 2.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9282 3.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9331 5.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6365 5.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3350 5.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3301 3.7470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6383 7.4936 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3399 8.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2998 7.6480 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 -2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3417 9.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1310 10.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5992 12.0361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0992 12.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5581 10.6031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6208 -3.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0015 -4.5024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0886 -3.6810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4743 -5.1347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9132 -5.5405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9658 -7.0329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5526 -7.5436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6496 -6.3797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2186 -8.6962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9601 -7.7049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 3 0
1 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
23 20 1 1
20 21 2 0
7 22 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
23 27 1 0
22 28 2 0
28 29 1 0
29 32 2 0
31 30 2 0
30 22 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 31 1 0
34 36 1 0
33 37 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 491.55Molecular Weight (Monoisotopic): 491.1957AlogP: 4.57#Rotatable Bonds: 5Polar Surface Area: 99.39Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.62CX Basic pKa: 9.49CX LogP: 3.72CX LogD: 1.66Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.43Np Likeness Score: -0.87
References 1. Boyd S, Brookfield JL, Critchlow SE, Cumming IA, Curtis NJ, Debreczeni J, Degorce SL, Donald C, Evans NJ, Groombridge S, Hopcroft P, Jones NP, Kettle JG, Lamont S, Lewis HJ, MacFaull P, McLoughlin SB, Rigoreau LJ, Smith JM, St-Gallay S, Stock JK, Turnbull AP, Wheatley ER, Winter J, Wingfield J.. (2015) Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3., 58 (8): [PMID:25849762 ] [10.1021/acs.jmedchem.5b00352 ]